BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform

WELLINGTON, New Zealand and KINGSTON, Ontario, April 07, 2026 (GLOBE NEWSWIRE) -- BioOra Limited ('BioOra'), a commercial-stage cell therapy ...
Seeking Alpha

Brainstorm Cell Therapeutics outlines imminent Phase 3b ALS trial launch following FDA clearance and expanded manufacturing plans

Chaim Lebovits, President and CEO, stated that "our unwavering primary focus remains the execution of the clinical development plan for NurOwn and the initiation of our pivotal Phase 3b trial designed ...
FiercePharma

Cellares' cell therapy factory-in-a-box scores coveted advanced manufacturing technology tag from FDA

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
ascopubs.org

Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in Mexico

Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study Healthy volunteers were recruited and underwent ...